Spruce Biosciences, Inc. (SPRB) Return on equity 2022–2025
Spruce Biosciences, Inc. (SPRB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-91.7%FY2025 · since FY2022: -67.4% → -91.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -91.7% | +92.4 pp |
| FY2024 | -184.0% | -121.4 pp |
| FY2023 | -62.6% | +4.8 pp |
| FY2022 | -67.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice